Active — Not RecruitingNot Applicable

Peri-conceptional or Pregnancy Exposure of Vaccination and the Risk of Adverse Pregnancy Outcomes

China150,000 participantsStarted 2024-01-01

Plain-language summary

Uing data from a population based cohort in China, we will conduct retrospective cohort study to evaluate the risk of vaccine (e.g., HPV/influenza/rabies vaccine) administered during pregnancy (especially during first trimester) for adverse pregnancy outcomes (e.g., birth defects, preterm birth and low birth weight)

Who can participate

Age range14 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All pregnant women in Xiamen who registry in our database. Exclusion Criteria: * Pregnant women who were lost to follow-up. Pregnant women exposed to related factors of known congenital malformation.

What they're measuring

Birth defects

Timeframe: From pregnancy to 42 days after delivery

Trial details

NCT IDNCT06180447

SponsorSun Xin

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-31

View on ClinicalTrials.gov More Vaccine Adverse Reaction trials